Results 161 to 170 of about 1,183,167 (309)

Effect of varenicline on major adverse liver outcomes in alcohol‐associated liver disease: An exploratory analysis

Alcohol, Clinical and Experimental Research, EarlyView.
This real‐world study assessed whether varenicline improves outcomes in patients with ALD and AUD. Using data from a large electronic health record network, 1278 matched patients were analyzed. Varenicline use was associated with reduced all‐cause mortality and hepatic encephalopathy compared with FDA‐approved AUD therapies (acamprosate or naltrexone),
Pojsakorn Danpanichkul, Yanfang Pang, Donghee Kim, Thanathip Suenghataiphorn, Donghyun Ko, Andrew F. Ibrahim, Vitchapong Prasitsumrit, Kwanjit Duangsonk, Mazen Noureddin, Karn Wijarnpreecha, Suthat Liangpunsakul   +10 more
wiley   +1 more source

Bradycardia and Other Arrhythmias in Patients With Hepatorenal Syndrome‐Acute Kidney Injury Following Terlipressin Treatment: A Pooled Analysis of Three North American Phase III Clinical Studies

Alimentary Pharmacology &Therapeutics, EarlyView.
In a pooled analysis, bradycardia was observed in 6% of terlipressin‐treated patients but rarely required a dose interruption or reduction. Arrhythmia serious adverse event incidences were low and similar in both treatment groups. Routine intensive cardiac monitoring for the detection of arrhythmias may not be necessary during terlipressin ...
Jasmohan S. Bajaj, Paul Kwo, Stephen Chris Pappas, Jacqueline G. O'Leary, Khurram Jamil, Sanaz Cardoza, Florence Wong   +6 more
wiley   +1 more source

Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non‐Acute Decompensation

Alimentary Pharmacology &Therapeutics, EarlyView.
The novel classification of acute and non‐acute decompensation provides prognostic information, but the role of hospitalisation status should be reconsidered. ABSTRACT Background A more granular understanding of hepatic decompensation in cirrhosis has led to the classification of acute decompensation (AD) and non‐acute decompensation (NAD).
Lucie Simonis, Lorenz Balcar, Anna Schedlbauer, Marta Tonon, Nikolaj Torp, Valeria Santori, Katharina Stopfer, Jan Embacher, Christian Sebesta, Leonie Hafner, Benedikt Silvester Hofer, Nina Dominik, Georg Kramer, Paul Thöne, Michael Trauner, Aleksander Krag, Salvatore Piano, Mattias Mandorfer, Thomas Reiberger, Georg Semmler   +19 more
wiley   +1 more source

Usefulness of A Portal Vein Stent for Sinistral Portal Hypertension: A Case Report. [PDF]

Surg Case Rep
Takimoto D, Ishida J, Toyama H, Nanno Y, Mizumoto T, Yoshida T, Urade T, Fukushima K, Gon H, Tsugawa D, Komatsu S, Yanagimoto H, Kido M, Fukumoto T.   +13 more
europepmc   +1 more source

Elastography methods for the non-invasive assessment of portal hypertension

Expert Review of Gastroenterology & Hepatology, 2018
D. Roccarina, M. Rosselli, J. Genescà, E. Tsochatzis   +3 more
semanticscholar   +1 more source

Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS

Alimentary Pharmacology &Therapeutics, EarlyView.
In patients with cirrhosis undergoing TIPS, frailty—measured by the Liver Frailty Index—improved in those with poor baseline status; therefore, high frailty should not be seen as a contraindication to elective TIPS. Additionally, LFI assessment before TIPS enables identification of patients with excellent survival prognosis.
Martin Andreas Kabelitz, Simon Johannes Gairing, Anja Tiede, Eva Maria Schleicher, Liv Grete Ahl, Lea Wagner, Falko Zucker‐Reimann, Hannah Rieland, Jim Benjamin Mauz, Julia Weinmann‐Menke, Bernhard C. Meyer, Michael Bernhard Pitton, Heiner Wedemeyer, Peter Robert Galle, Lisa Sandmann, Benjamin Maasoumy, Christian Labenz   +16 more
wiley   +1 more source

Revolutionising portal hypertension diagnosis: the rise of non-invasive techniques in liver cirrhosis. [PDF]

Front Med (Lausanne)
Gao B, Lin Y, Zhang H, Li Y, Gou S, Ma P, Zhao X, Zhou Y, Chen Q, Yuan L, Han Z, Yu C.   +11 more
europepmc   +1 more source

Portal Hypertension [PDF]

Postgraduate Medical Journal, 1947
openaire   +2 more sources

Burden of Invasive Fungal Diseases in Patients With Alcohol‐Related Hepatitis and Organ Failure

Alimentary Pharmacology &Therapeutics, EarlyView.
Between 2012 and 2021 in France, invasive fungal diseases affected 1 in 50 patients with alcohol‐related hepatitis and at least two hepatic or extrahepatic complications, with substantially higher mortality than bacterial pneumonia. These findings support targeted screening and early antifungal strategies in this population, as currently recommended ...
Charlotte Mouliade, Lucia Parlati, Stylianos Tzedakis, Mathis Collier, Samir Bouam, Philippe Sogni, Fanny Lanternier, Alexandre Alanio, Vincent Mallet, Demosthenes Research Group   +9 more
wiley   +1 more source

A Case of a Young Pregnant Patient With Congenital Portal Vein Stenosis, Portal Hypertension, and Liver Cirrhosis. [PDF]

Cureus
Alzain FA, Alolaian RJ, Alolayan AJ, Alolaian AJ, Albadrani YH.   +4 more
europepmc   +1 more source